These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase. Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825 [TBL] [Abstract][Full Text] [Related]
3. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918 [TBL] [Abstract][Full Text] [Related]
4. Lessons from human mutations in PPARgamma. Hegele RA Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581 [TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice. Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889 [TBL] [Abstract][Full Text] [Related]
6. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy. Liu L; Jiang Q; Wang X; Zhang Y; Lin RC; Lam SM; Shui G; Zhou L; Li P; Wang Y; Cui X; Gao M; Zhang L; Lv Y; Xu G; Liu G; Zhao D; Yang H Diabetes; 2014 Jul; 63(7):2320-31. PubMed ID: 24622797 [TBL] [Abstract][Full Text] [Related]
8. Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice. O'Donnell PE; Ye XZ; DeChellis MA; Davis VM; Duan SZ; Mortensen RM; Milstone DS PLoS One; 2016; 11(8):e0160636. PubMed ID: 27505464 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388 [TBL] [Abstract][Full Text] [Related]
10. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Jones JR; Barrick C; Kim KA; Lindner J; Blondeau B; Fujimoto Y; Shiota M; Kesterson RA; Kahn BB; Magnuson MA Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6207-12. PubMed ID: 15833818 [TBL] [Abstract][Full Text] [Related]
11. Impact of genetic variation of PPARgamma in humans. Meirhaeghe A; Amouyel P Mol Genet Metab; 2004; 83(1-2):93-102. PubMed ID: 15464424 [TBL] [Abstract][Full Text] [Related]
12. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. Zhou MS; Schulman IH; Raij L J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250 [TBL] [Abstract][Full Text] [Related]
13. Magnolol administration in normotensive young spontaneously hypertensive rats postpones the development of hypertension: role of increased PPAR gamma, reduced TRB3 and resultant alleviative vascular insulin resistance. Liang X; Xing W; He J; Fu F; Zhang W; Su F; Liu F; Ji L; Gao F; Su H; Sun X; Zhang H PLoS One; 2015; 10(3):e0120366. PubMed ID: 25793876 [TBL] [Abstract][Full Text] [Related]
14. PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Kintscher U; Law RE Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E287-91. PubMed ID: 15637349 [TBL] [Abstract][Full Text] [Related]
15. Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Agostini M; Schoenmakers E; Mitchell C; Szatmari I; Savage D; Smith A; Rajanayagam O; Semple R; Luan J; Bath L; Zalin A; Labib M; Kumar S; Simpson H; Blom D; Marais D; Schwabe J; Barroso I; Trembath R; Wareham N; Nagy L; Gurnell M; O'Rahilly S; Chatterjee K Cell Metab; 2006 Oct; 4(4):303-11. PubMed ID: 17011503 [TBL] [Abstract][Full Text] [Related]
16. PPARgamma in endothelial cells influences high fat diet-induced hypertension. Nicol CJ; Adachi M; Akiyama TE; Gonzalez FJ Am J Hypertens; 2005 Apr; 18(4 Pt 1):549-56. PubMed ID: 15831367 [TBL] [Abstract][Full Text] [Related]
17. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. He W; Barak Y; Hevener A; Olson P; Liao D; Le J; Nelson M; Ong E; Olefsky JM; Evans RM Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15712-7. PubMed ID: 14660788 [TBL] [Abstract][Full Text] [Related]
18. Delayed Hair Follicle Morphogenesis and Hair Follicle Dystrophy in a Lipoatrophy Mouse Model of Pparg Total Deletion. Sardella C; Winkler C; Quignodon L; Hardman JA; Toffoli B; Giordano Attianese GMP; Hundt JE; Michalik L; Vinson CR; Paus R; Desvergne B; Gilardi F J Invest Dermatol; 2018 Mar; 138(3):500-510. PubMed ID: 28964716 [TBL] [Abstract][Full Text] [Related]
19. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response. Malur A; Mccoy AJ; Arce S; Barna BP; Kavuru MS; Malur AG; Thomassen MJ J Immunol; 2009 May; 182(9):5816-22. PubMed ID: 19380830 [TBL] [Abstract][Full Text] [Related]